Download FREE Report Sample
Download Free sampleSunitinib Malate Market contains market size and forecasts of Sunitinib Malate (CAS 341031-54-7) in global, including the following market information:
Global Sunitinib Malate (CAS 341031-54-7) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sunitinib Malate (CAS 341031-54-7) Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Sunitinib Malate (CAS 341031-54-7) companies in 2021 (%)
The global Sunitinib Malate (CAS 341031-54-7) market was valued at 79 million in 2021 and is projected to reach US$ 166.3 million by 2028, at a CAGR of 11.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity Above 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sunitinib Malate (CAS 341031-54-7) include Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific and Target Molecule Corp., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sunitinib Malate (CAS 341031-54-7) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sunitinib Malate (CAS 341031-54-7) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Sunitinib Malate (CAS 341031-54-7) Market Segment Percentages, by Type, 2021 (%)
Purity Above 99%
Purity Above 98%
Purity Above 97%
Global Sunitinib Malate (CAS 341031-54-7) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Sunitinib Malate (CAS 341031-54-7) Market Segment Percentages, by Application, 2021 (%)
Advanced Kidney Cancer
GIST (Gastrointestinal Stromal Tumor)
Pancreatic Neuroendocrine Tumors
Global Sunitinib Malate (CAS 341031-54-7) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Sunitinib Malate (CAS 341031-54-7) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sunitinib Malate (CAS 341031-54-7) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sunitinib Malate (CAS 341031-54-7) revenues share in global market, 2021 (%)
Key companies Sunitinib Malate (CAS 341031-54-7) sales in global market, 2017-2022 (Estimated), (MT)
Key companies Sunitinib Malate (CAS 341031-54-7) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Sutent
Topcare pharmaceutical Co., Ltd
Nanjing First Pharmaceutical Co., Ltd.
J&K Scientific
Target Molecule Corp.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
